{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:06:55Z","timestamp":1774303615684,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Community's Seventh Framework Programme","doi-asserted-by":"publisher","award":["602300"],"award-info":[{"award-number":["602300"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.xphs.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T07:15:52Z","timestamp":1503126952000},"page":"3631-3641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia"],"prefix":"10.1016","volume":"106","author":[{"given":"Enrica","family":"Chiesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Paganini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Dorati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bice","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Modena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Genta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2017.08.004_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2340\/16501977-1116","article-title":"Health-related quality of life and socioeconomic situation among diastrophic dysplasia patients in Finland","volume":"45","author":"Kruger","year":"2013","journal-title":"J\u00a0Rehabil Med"},{"key":"10.1016\/j.xphs.2017.08.004_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0092-8674(94)90281-X","article-title":"The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping","volume":"78","author":"H\u00e4stbacka","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.xphs.2017.08.004_bib6","doi-asserted-by":"crossref","first-page":"22030","DOI":"10.1074\/jbc.M110.116467","article-title":"Matrix disruptions, growth, and degradation of cartilage with impaired sulfation","volume":"287","author":"Mertz","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2017.08.004_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bone.2013.01.036","article-title":"Alteration of proteoglycan sulfation affects bone growth and remodeling","volume":"54","author":"Gualeni","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.xphs.2017.08.004_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.semcdb.2011.03.004","article-title":"Sulfate in fetal development","volume":"22","author":"Dawson","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.xphs.2017.08.004_bib9","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jcb.24844","article-title":"Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation","volume":"115","author":"De Leonardis","year":"2014","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.xphs.2017.08.004_bib10","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1093\/hmg\/ddv289","article-title":"N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia","volume":"24","author":"Monti","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.xphs.2017.08.004_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0945-053X(98)90088-9","article-title":"Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production","volume":"17","author":"Rossi","year":"1998","journal-title":"Matrix Biol"},{"key":"10.1016\/j.xphs.2017.08.004_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/bj2520305","article-title":"Sulfation by cultured cells. Cysteine, cysteinesulfinic acid and sulfite as sources for proteoglycan sulfate","volume":"252","author":"Humphries","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/j.xphs.2017.08.004_bib13","doi-asserted-by":"crossref","first-page":"15725","DOI":"10.1016\/S0021-9258(18)66778-X","article-title":"Sulfate transport-deficient mutants of Chinese hamster ovary cells. Sulfation of glycosaminoglycans dependent on cysteine","volume":"261","author":"Esko","year":"1986","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2017.08.004_bib14","first-page":"L450","article-title":"Sulfation by human lung fibroblasts: SO42\u2212 and sulfur-containing amino acids as sources for macromolecular sulfation","volume":"260","author":"Elgavish","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.xphs.2017.08.004_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-4165(87)90230-3","article-title":"Amino acid sulfur as a source of sulfate for sulfated proteoglycans produced by Swiss mouse 3T3 cells","volume":"926","author":"Keller","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xphs.2017.08.004_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/BJ20060566","article-title":"In\u00a0vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation","volume":"398","author":"Pecora","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.xphs.2017.08.004_bib17","first-page":"4117","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"2013","author":"Samuni","year":"1830","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xphs.2017.08.004_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lfs.2016.03.003","article-title":"A\u00a0minireview on N-acetylcysteine: an old drug with new approaches","volume":"151","author":"Elbini Dhouib","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.xphs.2017.08.004_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s11239-015-1259-6","article-title":"The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura","volume":"41","author":"Rottenstreich","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.xphs.2017.08.004_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcf.2014.08.008","article-title":"Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial","volume":"14","author":"Conrad","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.xphs.2017.08.004_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1542\/peds.2013-3225","article-title":"Pediatric drug formulation: a review of challenges and progress","volume":"134","author":"Ivanoska","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.xphs.2017.08.004_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/1061186X.2013.765443","article-title":"Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity","volume":"21","author":"Alipour","year":"2013","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.xphs.2017.08.004_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0968051907085062","article-title":"Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries","volume":"13","author":"Alipour","year":"2007","journal-title":"J\u00a0Endotoxin Res"},{"key":"10.1016\/j.xphs.2017.08.004_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jat.1115","article-title":"Attenuation of half sulfur mustard gas-induced acute lung injury in rats","volume":"26","author":"McClintock","year":"2006","journal-title":"J\u00a0Appl Toxicol"},{"key":"10.1016\/j.xphs.2017.08.004_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2008.07.015","article-title":"Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents","volume":"363","author":"Mitsopoulos","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.08.004_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijpharm.2016.12.040","article-title":"Microphase separation in solid lipid dosage forms as the cause of drug release instability","volume":"517","author":"Lopes","year":"2017","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2017.08.004_bib27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11095-007-9430-1","article-title":"Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor","volume":"25","author":"Desai","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2017.08.004_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1517\/17425247.2012.655268","article-title":"Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases","volume":"9","author":"Sosnik","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2017.08.004_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1567201043334605","article-title":"Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery","volume":"1","author":"Avgoustakis","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.xphs.2017.08.004_bib30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","article-title":"Formulation of functionalized PLGA-PEG nanoparticles for in\u00a0vivo targeted drug delivery","volume":"28","author":"Cheng","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2017.08.004_bib31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1517\/17425240903044935","article-title":"Nanotechnology controlled drug delivery for treating bone diseases","volume":"6","author":"Yang","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"10.1016\/j.xphs.2017.08.004_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1517\/17425247.5.5.499","article-title":"Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles","volume":"5","author":"Wang","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2017.08.004_bib33","first-page":"1377","article-title":"Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization and cytotoxicities studies","volume":"7","author":"Martin-Banderas","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2017.08.004_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.nano.2009.02.002","article-title":"Pegylated PLGA nanoparticles for the improved delivery of doxorubicin","volume":"5","author":"Park","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2017.08.004_bib35","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2147\/IJN.S28481","article-title":"Role of hydroxy-propyl-beta-cyclodextrin on freeze dried and gamma irradiated PLGA and PLGA-PEG diblock copolymer nanospheres of ophthalmic flurbiprofen delivery","volume":"7","author":"Vega","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2017.08.004_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2013.05.037","article-title":"Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant","volume":"452","author":"Colonna","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.08.004_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2015.12.021","article-title":"Colonic gene silencing using siRNA-loaded calcium phosphate\/PLGA nanoparticles ameliorates intestinal inflammation in\u00a0vivo","volume":"222","author":"Frede","year":"2016","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.08.004_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","article-title":"PLGA nanoparticles in drug delivery: the state of the art","volume":"21","author":"Bala","year":"2004","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.xphs.2017.08.004_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.08.004_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.colsurfb.2010.06.002","article-title":"Development of biodegradable nanoparticles for delivery of quercetin","volume":"80","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2017.08.004_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"10.1016\/j.xphs.2017.08.004_bib42","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.xphs.2017.08.004_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/02652040801996763","article-title":"Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein","volume":"25","author":"Dorati","year":"2008","journal-title":"J\u00a0Microencapsul"},{"key":"10.1016\/j.xphs.2017.08.004_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0169-409X(02)00226-0","article-title":"PEGylated nanoparticles for biological and pharmaceutical applications","volume":"55","author":"Otsuka","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.08.004_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-012-1316-4","article-title":"Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system","volume":"14","author":"Locatelli","year":"2012","journal-title":"J\u00a0Nanopart Res"},{"key":"10.1016\/j.xphs.2017.08.004_bib46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2012.06.020","article-title":"Effects of block copolymer properties on nanocarrier protection from in\u00a0vivo clearance","volume":"162","author":"D'Addio","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.08.004_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","article-title":"The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres","volume":"16","author":"Gref","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.08.004_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.xphs.2017.08.004_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nano.2006.04.009","article-title":"Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems","volume":"2","author":"Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2017.08.004_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(03)00224-2","article-title":"Effect of copolymer composition on the physicochemical characteristics, in\u00a0vitro stability, and biodistribution of PLGA\u2013mPEG nanoparticles","volume":"259","author":"Avgoustakis","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.08.004_bib51","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.actbio.2014.07.015","article-title":"Aspartic acid-based modified PLGA\u2013PEG nanoparticles for bone targeting: in\u00a0vitro and in\u00a0vivo evaluation","volume":"10","author":"Fu","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2017.08.004_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijpharm.2005.03.024","article-title":"Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA\u2013PEG diblock copolymers","volume":"298","author":"Beletsi","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.08.004_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2015.10.005","article-title":"Targeted delivery to bone and mineral deposits using bisphosphonate ligands","volume":"99","author":"Cole","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.08.004_bib54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jconrel.2011.11.020","article-title":"Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel","volume":"158","author":"Chaudhari","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.08.004_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejps.2004.09.011","article-title":"Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles","volume":"24","author":"Bilati","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2017.08.004_bib56","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ijpharm.2016.08.011","article-title":"Design of smart GE11-PLGA\/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in\u00a0vitro\/ex\u00a0vivo characterization","volume":"511","author":"Colzani","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.08.004_bib57","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1039\/c3ay40426a","article-title":"A\u00a0LC-UV method to assay N-acetylcysteine without derivatization: analyses of pharmaceutical products","volume":"5","author":"Ourique","year":"2013","journal-title":"Anal Methods"},{"key":"10.1016\/j.xphs.2017.08.004_bib58","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.08.004_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2016.01.034","article-title":"Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery","volume":"225","author":"Fonte","year":"2016","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.08.004_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2012.10.022","article-title":"Methodology for a rapid and simultaneous determination of total cysteine, homocysteine, cysteinylglycine and glutathione in plasma by isocratic RP-HPLC","volume":"911","author":"Ferin","year":"2012","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.xphs.2017.08.004_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","article-title":"Polymer-based nanocapsules for drug delivery","volume":"385","author":"Mora-Huertas","year":"2010","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2017.08.004_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02652048.2011.569763","article-title":"The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers","volume":"28","author":"Grabnar","year":"2011","journal-title":"J\u00a0Microencapsul"},{"key":"10.1016\/j.xphs.2017.08.004_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2005.12.003","article-title":"Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles","volume":"2","author":"Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2017.08.004_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/794601","article-title":"Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with antisolvent","volume":"2015","author":"Sah","year":"2015","journal-title":"J\u00a0Nanomater"},{"key":"10.1016\/j.xphs.2017.08.004_bib65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijpharm.2016.01.020","article-title":"Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges","volume":"499","author":"Ramazani","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2017.08.004_bib66","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/0142-9612(96)00049-X","article-title":"Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide)","volume":"17","author":"Lemoine","year":"1996","journal-title":"Biomaterials"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917305683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917305683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T13:37:26Z","timestamp":1659361046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917305683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0022354917305683"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.08.004","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}